Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1451116983
总结
CYP2C19 poor metabolizer and intermediate metabolizer genotypes are associated with increased risk of major adverse cardiac events (mace) when treated with clopidogrel in people with percutaneous coronary intervention.